Symbol="MYMD"
AssetType="Common Stock"
Name="MyMD Pharmaceuticals Inc"
Description="MyMD Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, is dedicated to the development of pharmaceutical products targeting aging and age-related diseases; Autoimmune diseases; and chronic pain, anxiety, and sleep disorders. The company is headquartered in Tampa, Florida."
CIK="1321834"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES"
Address="201 GROVE RD, THOROFARE, NJ, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="44872000"
EBITDA="-28182912"
PERatio="None"
PEGRatio="None"
BookValue="0.327"
DividendPerShare="0"
DividendYield="0"
EPS="-0.35"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.321"
ReturnOnEquityTTM="-0.749"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-0.35"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="None"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="3.083"
EVToRevenue="-"
EVToEBITDA="-3.332"
Beta="4.096"
num_52WeekHigh="6.15"
num_52WeekLow="0.8"
num_50DayMovingAverage="1.509"
num_200DayMovingAverage="1.792"
SharesOutstanding="39605100"
DividendDate="2019-11-25"
ExDividendDate="None"
symbol="MYMD"
open="1.35"
high="1.58"
low="1.14"
price="1.45"
volume="6284121.00"
latest_trading_day="2023-07-31"
previous_close="1.10"
change="0.35"
change_percent="31.8182%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="49"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="51"
Volume_recent_avg="613117"
Change_recent_avg="-0.02"
Delta_recent_avg="0.16"
Variance_recent_avg="0.08"
Change_ratio_recent_avg="-1.54"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="51"
Aroon_momentum_negative="49"
image_negative_thumbnail_id_1="517"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0088.jpeg"
image_negative_thumbnail_id_2="112"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0064.jpeg"
image_neutral_thumbnail_id_1="432"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Neutral_Landscape_0019.jpeg"
image_neutral_thumbnail_id_2="596"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0003.jpeg"
image_positive_thumbnail_id_1="982"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0144.jpeg"
image_positive_thumbnail_id_2="706"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0002.jpeg"
image_professor_thumbnail_id_1="1184"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0018.jpeg"
image_professor_thumbnail_id_2="1169"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0003.jpeg"
